Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.
What is Akari Therapeutics's quote symbol?
What is the 52 week high and low for Akari Therapeutics (NASDAQ: AKTX)?
How much is Akari Therapeutics stock worth today?
How much is Akari Therapeutics's stock price per share?
What is Akari Therapeutics's Market Cap?